Roche receives FDA approval for Ventana CLDN18 RxDx Assay
Roche (RHHBY) announced that the VENTANA CLDN18 RxDx Assay is the first U.S. Food and Drug Administration approved ...
devdiscourse8h
Health Sector Headlines: From FDA Approvals to CEO Transitions
Recent health news includes FDA's approval of Astellas' gastric cancer therapy, the resignation of CVS Health CEO Karen Lynch ...
devdiscourse15h
Health Headlines: FDA Greenlights Cancer Therapy, Leadership Shakeup at CVS, and Global Health Insights
The FDA approved Astellas' gastric cancer therapy. CVS Health CEO Karen Lynch steps down amid shareholder pressure, with ...
The Pharma Letter17h
FDA approves Astellas’ Vyloy
The US Food and Drug Administration has approved Vyloy (zolbetuximab-clzb), a claudin 18.2 (CLDN18.2)-directed cytolytic ...
ARY News Live20h
VYLOY: Astellas’ gastric cancer therapy approved in US
Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...